{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T19:06:57Z","timestamp":1768072017967,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T00:00:00Z","timestamp":1454976000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00277-016-2606-1","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T23:58:08Z","timestamp":1454975888000},"page":"745-750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults"],"prefix":"10.1007","volume":"95","author":[{"given":"Xin-xin","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding-rong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-hui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-yong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao-bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,9]]},"reference":[{"key":"2606_CR1","first-page":"208","volume":"329","author":"Writing Group of the Histiocyte Society","year":"1987","unstructured":"Writing Group of the Histiocyte Society (1987) Histiocytosis syndromes in children. Lancet 329:208\u2013209","journal-title":"Lancet"},{"key":"2606_CR2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00000478-199506000-00003","volume":"19","author":"JF Emile","year":"1995","unstructured":"Emile JF, Wechsler J, Brousse N et al (1995) Langerhans\u2019 cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. Am J Surg Pathol 19:636\u2013641","journal-title":"Am J Surg Pathol"},{"key":"2606_CR3","unstructured":"International Agency for Research in Cancer (2006) World Health Organization Classification of tumours: pathology and genetics of tumours of the skin. Lyon"},{"key":"2606_CR4","unstructured":"International Agency for Research in Cancer (2008) WHO Classification of tumours of haematopoietic and lymphoid tissues. Lyon"},{"key":"2606_CR5","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","volume":"120","author":"J Haroche","year":"2012","unstructured":"Haroche J, Charlotte F, Arnaud L et al (2012) High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood 120:2700\u20132703","journal-title":"Blood"},{"key":"2606_CR6","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1200\/JCO.2012.43.2260","volume":"30","author":"P Blombery","year":"2012","unstructured":"Blombery P, Wong SQ, Lade S, Prince HM (2012) Erdheim-Chester disease harboring the BRAF V600E mutation. J Clin Oncol 30:e331\u2013e332","journal-title":"J Clin Oncol"},{"key":"2606_CR7","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.18632\/oncotarget.2061","volume":"5","author":"AM Bubolz","year":"2014","unstructured":"Bubolz AM, Weissinger SE, Stenzinger A et al (2014) Potential clinical implications of BRAF mutations in histiocytic proliferations. Oncotarget 5:4060\u20134070","journal-title":"Oncotarget"},{"key":"2606_CR8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","volume":"124","author":"EL Diamond","year":"2014","unstructured":"Diamond EL, Dagna L, Hyman DM et al (2014) Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood 124:483\u2013492","journal-title":"Blood"},{"key":"2606_CR9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.rdc.2013.02.011","volume":"39","author":"J Haroche","year":"2013","unstructured":"Haroche J, Arnaud L, Cohen-Aubart F et al (2013) Erdheim-Chester disease. Rheum Dis Clin N Am 39:299\u2013311","journal-title":"Rheum Dis Clin N Am"},{"key":"2606_CR10","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/annrheumdis-2013-204924","volume":"74","author":"MG Cangi","year":"2015","unstructured":"Cangi MG, Biavasco R, Cavalli G et al (2015) BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease. Ann Rheum Dis 74:1596\u20131602","journal-title":"Ann Rheum Dis"},{"key":"2606_CR11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood-2013-12-543793","volume":"124","author":"B Hervier","year":"2014","unstructured":"Hervier B, Haroche J, Arnaud L et al (2014) Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Blood 124:1119\u20131126","journal-title":"Blood"},{"key":"2606_CR12","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1002\/art.22280","volume":"54","author":"A Stoppacciaro","year":"2006","unstructured":"Stoppacciaro A, Ferrarini M, Salmaggi C et al (2006) Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis. Arthritis Rheum 54:4018\u20134022","journal-title":"Arthritis Rheum"},{"key":"2606_CR13","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2010-10-313510","volume":"117","author":"L Arnaud","year":"2011","unstructured":"Arnaud L, Gorochov G, Charlotte F et al (2011) Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients. Blood 117:2783\u20132790","journal-title":"Blood"},{"key":"2606_CR14","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1182\/blood-2010-04-279240","volume":"116","author":"A Aouba","year":"2010","unstructured":"Aouba A, Georgin-Lavialle S, Pagnoux C et al (2010) Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood 116:4070\u20134076","journal-title":"Blood"},{"key":"2606_CR15","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood-2005-06-2238","volume":"106","author":"F Braiteh","year":"2005","unstructured":"Braiteh F, Boxrud C, Esmaeli B, Kurzrock R (2005) Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-\u03b1. Blood 106:2992\u20132994","journal-title":"Blood"},{"key":"2606_CR16","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/annrheumdis-2012-202542","volume":"72","author":"G Cavalli","year":"2013","unstructured":"Cavalli G et al (2013) The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases. Ann Rheum Dis 72:1691\u20131695","journal-title":"Ann Rheum Dis"},{"key":"2606_CR17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","volume":"33","author":"J Haroche","year":"2015","unstructured":"Haroche J, Cohen-Aubart F, Emile JF et al (2015) Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAFV600E-mutated Erdheim-Chester disease. J Clin Oncol 33:411\u2013418","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2606-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2606-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2606-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T05:50:04Z","timestamp":1559022604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2606-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2606"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2606-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,9]]}}}